Your English writing platform
Discover LudwigExact(9)
Two double-blind, randomized, placebo-controlled clinical trials for the treatment of chronic migraine with onabotulinumtoxinA, the Phase III REarch Evaluating Migraine Prophylaxis Therapy (PREEMPT) 1 and 2 as well as the pooled data from the two trials were recently published [3 5].
The results of two pidilizumab clinical trials were recently published in peer-reviewed journals.
The results of the latest Cochrane meta-analysis using individual patient data from 53 ESA trials were recently published in the Lancet (Bohlius et al, 2009a, 2009b).
Two large trials were recently published showing no significant difference in readmission for patients with heart failure participating in a telemonitoring program as compared to the control group [ 25, 26].
In this regard, two prehospital intervention trials were recently successfully designed and implemented to compare hypertonic saline resuscitation with or without dextran versus conventional isotonic resuscitation in patients with hypovolemic shock or traumatic brain injury [ 96].
Motivated by encouraging bench-scale results, pilot-scale field trials were recently conducted at five sites in the U.S. and Norway as shown in Figure S1 and Table S1 in the Supporting Information.
Similar(51)
The progress of various such trials was recently reviewed by Hu and coworkers [ 53].
A thought provoking synthesis of the MMP experimental studies and clinical trials was recently reported by Matrisian and colleagues [ 54].
Only one clinical trials was recently performed (HARMONY, EudraCT-Nr: 2011-001134-42), investigalone ranorazine alone or in combination with dronedarone with respect to atrial fibrillation burden in subjects with paroxysmal atrial fibrillation and implanted pacemakers.
The ventilator settings used in our trial were recently used in a similar trial involving pigs that did not demonstrate the anatomical or histological changes characteristic of ARDS [23].
The survival data from this trial were recently updated.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com